| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.5 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |